Pay in 4 interest-free payments of $6.05 Learn more
Ships within 48 hours · Estimated delivery Aug 9 - Aug 14
Coverage decisions, prior authorization criteria and diagnosis coding all key off the approved indication
RESEARCH AREAS Pan-ERR (ERR//) receptor binding and agonist activation mechanisms Transcriptional regulation of mitochondrial biogenesis pathways in cell models Modulation of oxidative phosphorylation and fatty-acid oxidation gene sets PGC-1/ERR signaling-axis interactions in cultured myocyte systems WHAT RESEARCHERS LOOK AT Receptor-binding affinity and isoform selectivity assays Reporter-gene transcriptional activation readouts in transfected cell lines qPCR/RNA-seq profiling of ERR target-gene expression in vitro Compound stability, solubility, and purity verification by HPLC and mass spectrometry QUICK SPECS Form: Capsule not for ingestion Net per capsule: 100mcg Count: 60 capsules per bottle Purity: 98% (HPLC) Identity: Confirmed by mass spectrometry Storage: Cool, dry conditions away from light IDENTITY BASICS Type: Synthetic small-molecule ERR agonist (non-peptide) Molecular Formula: CHClNO Molecular Weight: ~426.9 g/mol CAS: 2756409-79-1 SELECTED RESEARCH PubChem: SLU-PP-332 compound record PubMed: ERR agonist SLU-PP-332 studies PubMed: ERR and mitochondrial biogenesis PubMed: ERR oxidative metabolism regulation DISCLAIMER For laboratory research use only
Jetzt kann das Abnehmen endlich beginnen
According to research published in the Journal of the American Medical Association, "Semaglutide has been associated with reductions in food cravings, which is less evident with liraglutide. The same is observed for tirzepatide
An alternative hypothesis suggests that the activation of GLP-1R may influence the gut microbiome in ways that could impact both metabolic and neurological aging
